Drug makers resist pressure from Washington on prices
From the article:
"Much of what the Department of Health & Human Services has done so far consists of putting forward proposals, largely involving what Medicare will pay for medications.
One of the more significant plans would set the reimbursement level for certain drugs administered in doctors' offices and hospital outpatient centers based on their cost in other countries, which typically pay far less. The so-called International Pricing Index model has already faced blow back from many quarters, including Republican lawmakers.
But so far, most of the efforts have been on the margins. 'The rhetoric they are using is out of scale with their proposals,' said Rachel Sachs, an associate law professor at Washington University who studies drug pricing."
Read more here!health law policy pharmaceuticals rachel sachs